Literature DB >> 22065714

2-(3H-1,3-Benzothia-zol-2-yl-idene)-propane-dial.

Hamid Ennajih, Rachid Bouhfid, Stephane Massip, Jean Michel Leger, El Mokhtar Essassi.   

Abstract

In the title compound, C(10)H(7)NO(2)S, the dihedral angle between the benzimidazole and malonaldehyde group is 1.41 (2)°. An intra-molecular hydrogen bond is formed between the NH group and one of the adjacent carbonyl O atoms. In addition, the NH group forms an inter-molecular hydrogen bond to a symmetry equivalent of this carbonyl O atom, connecting the mol-ecules into centrosymmetric dimers. The structure also contains C-H⋯O inter-molecular inter-actions.

Entities:  

Year:  2011        PMID: 22065714      PMCID: PMC3200844          DOI: 10.1107/S1600536811030248

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For biological activities of benzothia­zole derivatives, see: Mortimer et al. (2006 ▶); Yoshida et al. (2005 ▶); Vicini et al. (2003 ▶).

Experimental

Crystal data

C10H7NO2S M = 205.23 Monoclinic, a = 8.3927 (10) Å b = 5.0972 (8) Å c = 20.739 (2) Å β = 100.098 (8)° V = 873.4 (2) Å3 Z = 4 Cu Kα radiation μ = 3.05 mm−1 T = 133 K 0.12 × 0.12 × 0.02 mm

Data collection

Rigaku R-AXIS RAPID diffractometer Absorption correction: multi-scan (CrystalClear; Rigaku/MSC, 2005 ▶) T min = 0.711, T max = 0.942 10660 measured reflections 1569 independent reflections 1475 reflections with I > 2σ(I) R int = 0.082

Refinement

R[F 2 > 2σ(F 2)] = 0.067 wR(F 2) = 0.165 S = 1.02 1569 reflections 128 parameters H-atom parameters constrained Δρmax = 0.60 e Å−3 Δρmin = −0.45 e Å−3 Data collection: CrystalClear (Rigaku/MSC, 2005 ▶); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: PLATON (van der Sluis & Spek, 1990 ▶; Spek, 2009 ▶); software used to prepare material for publication: publCIF (Westrip, 2010 ▶). Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536811030248/hg5064sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536811030248/hg5064Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536811030248/hg5064Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C10H7NO2SF(000) = 424
Mr = 205.23Dx = 1.561 Mg m3
Monoclinic, P21/cCu Kα radiation, λ = 1.54180 Å
Hall symbol: -P 2ybcCell parameters from 1475 reflections
a = 8.3927 (10) Åθ = 7.5–71.9°
b = 5.0972 (8) ŵ = 3.05 mm1
c = 20.739 (2) ÅT = 133 K
β = 100.098 (8)°Plate, colourless
V = 873.4 (2) Å30.12 × 0.12 × 0.02 mm
Z = 4
Rigaku R-AXIS RAPID diffractometer1569 independent reflections
Radiation source: micro-focus rotating anode1475 reflections with I > 2σ(I)
confocalRint = 0.082
ω scansθmax = 71.9°, θmin = 7.5°
Absorption correction: multi-scan (CrystalClear; Rigaku/MSC, 2005)h = −10→10
Tmin = 0.711, Tmax = 0.942k = −4→5
10660 measured reflectionsl = −25→25
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.067Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.165H-atom parameters constrained
S = 1.02w = 1/[σ2(Fo2) + (0.098P)2 + 1.503P] where P = (Fo2 + 2Fc2)/3
1569 reflections(Δ/σ)max < 0.001
128 parametersΔρmax = 0.60 e Å3
0 restraintsΔρmin = −0.45 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
C10.6870 (3)0.3667 (6)0.16032 (14)0.0291 (7)
H10.61620.22100.16000.035*
C20.7501 (3)0.4952 (7)0.21783 (13)0.0311 (7)
H20.72160.43660.25780.037*
C30.8986 (3)0.7993 (6)0.16137 (14)0.0272 (6)
H30.97060.94340.16190.033*
C40.8343 (3)0.6732 (6)0.10311 (13)0.0256 (6)
C50.7315 (3)0.4596 (6)0.10291 (13)0.0255 (6)
N60.6804 (3)0.3641 (5)0.03972 (11)0.0248 (6)
H60.61450.22940.03130.030*
C70.7391 (3)0.4926 (6)−0.00706 (13)0.0248 (6)
S80.86490 (8)0.74932 (13)0.02434 (3)0.0253 (3)
C90.7044 (3)0.4279 (6)−0.07455 (13)0.0267 (7)
C100.6013 (3)0.2122 (6)−0.09676 (14)0.0267 (7)
H100.58560.1748−0.14230.032*
O110.5306 (2)0.0694 (4)−0.06329 (9)0.0303 (5)
C120.8543 (4)0.7080 (6)0.21876 (14)0.0308 (7)
H120.89550.79190.25920.037*
C130.7714 (3)0.5777 (6)−0.12103 (14)0.0303 (7)
H130.74470.5248−0.16550.036*
O140.8605 (3)0.7691 (4)−0.10910 (11)0.0343 (6)
U11U22U33U12U13U23
C10.0248 (13)0.0302 (18)0.0337 (14)0.0004 (12)0.0085 (11)0.0039 (12)
C20.0296 (14)0.037 (2)0.0280 (14)0.0031 (13)0.0094 (11)0.0059 (12)
C30.0231 (13)0.0296 (17)0.0300 (14)0.0009 (12)0.0079 (11)−0.0012 (12)
C40.0205 (12)0.0312 (17)0.0266 (13)0.0034 (11)0.0087 (10)0.0026 (12)
C50.0197 (12)0.0278 (17)0.0294 (14)0.0042 (11)0.0052 (10)−0.0001 (11)
N60.0200 (11)0.0268 (15)0.0287 (11)−0.0004 (10)0.0071 (8)−0.0004 (9)
C70.0176 (12)0.0264 (17)0.0318 (14)0.0032 (11)0.0084 (10)0.0007 (11)
S80.0225 (4)0.0277 (5)0.0274 (5)−0.0021 (2)0.0090 (3)0.0003 (2)
C90.0213 (13)0.0307 (18)0.0295 (14)0.0040 (11)0.0082 (10)0.0010 (11)
C100.0218 (13)0.0316 (18)0.0277 (14)0.0040 (11)0.0070 (11)0.0002 (11)
O110.0262 (10)0.0315 (13)0.0341 (10)−0.0017 (8)0.0083 (8)0.0019 (9)
C120.0295 (15)0.0367 (19)0.0263 (14)0.0045 (12)0.0053 (11)−0.0022 (12)
C130.0276 (14)0.0352 (19)0.0303 (14)0.0030 (13)0.0109 (11)0.0003 (12)
O140.0333 (12)0.0377 (15)0.0353 (12)−0.0053 (9)0.0151 (9)0.0016 (9)
C1—C21.382 (4)N6—C71.334 (4)
C1—C51.392 (4)N6—H60.8800
C1—H10.9500C7—C91.418 (4)
C2—C121.391 (4)C7—S81.735 (3)
C2—H20.9500C9—C131.421 (4)
C3—C121.388 (4)C9—C101.425 (4)
C3—C41.391 (4)C10—O111.228 (4)
C3—H30.9500C10—H100.9500
C4—C51.388 (4)C12—H120.9500
C4—S81.741 (3)C13—O141.228 (4)
C5—N61.393 (3)C13—H130.9500
C2—C1—C5117.2 (3)C5—N6—H6122.6
C2—C1—H1121.4N6—C7—C9124.4 (3)
C5—C1—H1121.4N6—C7—S8112.0 (2)
C1—C2—C12121.8 (3)C9—C7—S8123.5 (2)
C1—C2—H2119.1C7—S8—C490.23 (13)
C12—C2—H2119.1C7—C9—C13120.5 (3)
C12—C3—C4117.9 (3)C7—C9—C10120.4 (3)
C12—C3—H3121.0C13—C9—C10119.1 (3)
C4—C3—H3121.0O11—C10—C9126.9 (3)
C5—C4—C3120.7 (3)O11—C10—H10116.5
C5—C4—S8111.4 (2)C9—C10—H10116.5
C3—C4—S8127.8 (2)C3—C12—C2120.8 (3)
C4—C5—C1121.6 (3)C3—C12—H12119.6
C4—C5—N6111.4 (2)C2—C12—H12119.6
C1—C5—N6126.9 (3)O14—C13—C9126.2 (3)
C7—N6—C5114.9 (2)O14—C13—H13116.9
C7—N6—H6122.6C9—C13—H13116.9
C5—C1—C2—C12−0.2 (4)C9—C7—S8—C4−179.5 (2)
C12—C3—C4—C5−1.2 (4)C5—C4—S8—C70.0 (2)
C12—C3—C4—S8178.5 (2)C3—C4—S8—C7−179.7 (3)
C3—C4—C5—C11.1 (4)N6—C7—C9—C13179.4 (2)
S8—C4—C5—C1−178.7 (2)S8—C7—C9—C13−1.0 (4)
C3—C4—C5—N6179.7 (3)N6—C7—C9—C10−0.3 (4)
S8—C4—C5—N6−0.1 (3)S8—C7—C9—C10179.3 (2)
C2—C1—C5—C4−0.3 (4)C7—C9—C10—O112.1 (4)
C2—C1—C5—N6−178.7 (3)C13—C9—C10—O11−177.7 (3)
C4—C5—N6—C70.2 (3)C4—C3—C12—C20.7 (4)
C1—C5—N6—C7178.7 (3)C1—C2—C12—C30.0 (5)
C5—N6—C7—C9179.4 (2)C7—C9—C13—O14−0.4 (5)
C5—N6—C7—S8−0.2 (3)C10—C9—C13—O14179.3 (3)
N6—C7—S8—C40.1 (2)
D—H···AD—HH···AD···AD—H···A
N6—H6···O110.882.132.731 (3)125.
N6—H6···O11i0.882.132.926 (3)151.
C3—H3···O14ii0.952.433.297 (4)152.
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
N6—H6⋯O110.882.132.731 (3)125
N6—H6⋯O11i0.882.132.926 (3)151
C3—H3⋯O14ii0.952.433.297 (4)152

Symmetry codes: (i) ; (ii) .

  5 in total

1.  Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.

Authors:  Catriona G Mortimer; Geoffrey Wells; Jean-Philippe Crochard; Erica L Stone; Tracey D Bradshaw; Malcolm F G Stevens; Andrew D Westwell
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

2.  Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents.

Authors:  Masao Yoshida; Ichiro Hayakawa; Noriyuki Hayashi; Toshinori Agatsuma; Youko Oda; Fumie Tanzawa; Shiho Iwasaki; Kumiko Koyama; Hidehiko Furukawa; Shinichi Kurakata; Yuichi Sugano
Journal:  Bioorg Med Chem Lett       Date:  2005-07-15       Impact factor: 2.823

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

4.  Synthesis and biological evaluation of benzo[d]isothiazole, benzothiazole and thiazole Schiff bases.

Authors:  Paola Vicini; Athina Geronikaki; Matteo Incerti; Bernadetta Busonera; Graziella Poni; Carla Alba Cabras; Paolo La Colla
Journal:  Bioorg Med Chem       Date:  2003-11-03       Impact factor: 3.641

5.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.